Hypertension meetings & conferences

5th International Conference on Fixed Combination in the Treatment of Hypertension, Dyslipidemia and Diabetes Mellitus

21-24 November, 2013 Bangkok, Thailand

Fixed combination has recently made a comeback as an initial therapy in the treatment of hypertension. The additive or synergistic effect of combination therapy fully lowers blood pressure in patients who tend to have less than full response to one component only. Antihypertensive monotherapy does not address the multifactorial nature of hypertension as a disease with many pathways; using more than one drug makes more therapeutic sense, as combined agents cover more than one etiology.

Importance of anti-diabetic and anti-lipidemic combinations should be emphasized as well: Many patients with diabetes mellitus may also be treated with dual pharmacological therapy as fixed combination: two or more drugs acting on different pathophysiological process is often  necessary to reach  early and sustained achievement of individualized  glycemic targets. At the same time choosing the safest option to avoid hypoglycemia is of paramount importance compared with loose pill, both statin and anti-diabetic combination therapies may also have better adherence, improved satisfaction and lower drug costs.

The conference is intended for experts in the fields of diabetes, hypertension, dyslipidemia, internal medicine, cardiology, endocrinology, nephrology, hyperlipidemia, family medicine, primary care physicians, nurse practitioners and physicians’ assistants. All are invited to explore the current and future role of fixed combinations in the treatment of hypertension, dyslipidemia and diabetes.

List of Topics

•  Treatment Simplification and Compliance

•  FDCs as First Step Treatment

•  FDC in Secondary Prevention

•  FDCs of Antihypertensive and Antidiabetic Drugs

•  FDCs of Antihypertensive and Lipid Lowering Drugs

•  FDC in the Elderly and Very Elderly

•  Ambulatory BP in the Assessment of FDC Efficacy

•  Home BP in the Assessment of FDC Efficacy

•  Combinations with Thiazides. Chlortalidone vs HCTZ

•  ACE Inhibitors  and  Diuretics FDC

•  ACE Inhibitors  and  Calcium Channel Blockers FDC

•  ARBs  and Diuretics  FDC

•  ARBs  and Calcium Channel Blockers  FDC

•  Triple Drug Combinations

•  The Polypills

•  FDCs as Generic Drugs

•  Guidelines

•  FDCs in Different Countries

•  Regulatory Aspects

•  Cost Issues

Contact Us

Conference Organizers

Paragon Conventions
18 Avenue Louis-Casai
1209 Geneva, Switzerland
Tel:  +41 (0)22 533 0948    
Fax: +41 (0)22 580 2953

General Enquiries

Noa Beer-Raveh - Project Manager
fixed2013@fixedcombination.com  
Fax: +41 (0)22 580 2953

Third International Congress on Cardiac Problems in Pregnancy

February 20-23, 2014 Venice, Italy

The goals of “The Third International Congress on Cardiac Problems in Pregnancy” are to continue advancing the knowledge and expertise of health care professionals around the globe by exchange of information, development of collaborative research both basic and clinical, discuss, adopt and upgrade recent guidelines for the management of cardiovascular conditions during pregnancy and the post partal period. The program will include invited lectures, workshops as well as original oral and poster presentations which will cover a wide spectrum of topics in all disciplines related to pregnancy associated cardiovascular conditions.

Who Should Attend?

This Congress is intended for:

Cardiologists

Gynecologists

Obstetricians

Anesthesiologists

Internists

Hypertension specialists

Medical Imaging Technicians

10th Asia Pacific Congress of Hypertension (APCH 2014)

12-15 February 2014 Cebu City, Philippines

Join colleagues and leading specialists in Cebu City, Philippines, 12-15 February 2014, for this major educational forum - established to advance the clinical and scientific understanding of hypertension and to improve the treatment of hypertension and related vascular disorders in the community.

The 10th Asia Pacific Congress of Hypertension (APCH 2014) is a biennial event organized by the Asia Pacific Society for Hypertension (APSH) that aims to promote public education, better care and facilitate research and collaboration in the field of hypertension. Due to its size and scope, the meeting offers unique networking opportunities:

APSH is the official affiliate of the International Society of Hypertension (ISH) for Asia Pacific.

At each APCH gathering, there is a joint symposium with the ISH.

APCH 2014 will build on highly successful congresses in Sydney, Taipei and Kuala Lumpur.

18th World Congress on Heart Disease

International Academy of Cardiology, 18th World Congress on Heart Disease, Annual Scientific Sessions 2013

July 26-29, 2013 Vancouver, BC, Canada

The Congress will provide the opportunity for a comprehensive overview of the latest research developments in cardiovascular medicine, primarily in the areas of Molecular and Cellular Cardiology, Genetics of Heart Disease, Cardiac Imaging, Coronary Artery Disease, Peripheral Arterial Disease, Interventional Cardiology, Lipoprotein Disorders, Hypertension, Metabolic Syndrome, Heart Failure, Valvular Heart Disease, Diseases of the Aorta, Cardiac Arrhythmias and Electrophysiology, Implantable Cardiac Pacemakers and Cardioverter-Defibrillators, Sudden Cardiac Death, Pediatric Cardiology, Congenital Heart Disease, Cardiac Surgery, Heart Transplantation, Mechanical Circulatory Support and Measurement of Outcome and Quality of Cardiovascular Care.

For further information:

International Academy of Cardiology
18th World Congress on Heart Disease
Annual Scientific Sessions 2013
PO Box 17659, Beverly Hills, CA 90209, USA
Tel: +1 310 657 8777; Fax: +1 310 659 4781
e-Mail: Klimedco@ucla.edu